Assenagon Asset Management
CDLX icon

Assenagon Asset Management’s Cardlytics CDLX Stock Holding History

Assenagon Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,497
Closed -$652K – 1427
2024
Q1 		$652K Sell
4,497
-5,238
-54% -$442K ﹤0.01% 1148
2023
Q4 		$897K Buy
9,735
+8,215
+540% +$835K ﹤0.01% 1124
2023
Q3 		$251K Sell
1,520
-9,387
-86% -$1.22M ﹤0.01% 1314
2023
Q2 		$689K Sell
10,907
-24,377
-69% -$1.48M ﹤0.01% 1064
2023
Q1 		$1.2M Buy
+35,284
New +$1.84M ﹤0.01% 990
2022
Q3 		– Sell
-38,642
Closed -$8.62M – 1362
2022
Q2 		$8.62M Buy
+38,642
New +$12.9M 0.03% 408

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PIP
PB Investment Partners Burlingame, California $127M AUM 0.83% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BCM
Brightlight Capital Management Westport, Connecticut $101M AUM 23.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management's CDLX Position: Q2 2024 in Review

Assenagon Asset Management sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 4,497 shares — an estimated $652K sold.

Assenagon Asset Management first reported a position in CDLX in Q2 2022 and held it in 6 quarters. The position peaked at $8.62M in Q2 2022. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Assenagon Asset Management reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 4,497 Cardlytics shares in Q2 2024, an estimated $652K.
  • Assenagon Asset Management first reported a position in Cardlytics in Q2 2022 and held it in 6 quarters.
  • Assenagon Asset Management's Cardlytics position peaked at $8.62M in Q2 2022.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Assenagon Asset Management's 13F filing for Q2 2024, filed 18 Jul 2024.